SANAI HEALTH GP (01889) issues profit warning, expecting a loss of about 25.5 million to 27.5 million yuan for the year 2025.

date
00:11 28/03/2026
avatar
GMT Eight
Sanai Health Group (01889) announced that the company is expected to incur a loss of between RMB 25.5 million and 27.5 million for the financial year ending December 31, 2025, while it made a profit of approximately RMB 3.4 million for the same period in 2024.
SANAI HEALTH GP (01889) announced that the company is expected to incur a loss ranging from RMB 25.50 million to 27.50 million for the year ending December 31, 2025, while it recorded a profit of approximately RMB 3.40 million in the same period in 2024. The shift from a profit in 2024 to a loss in 2025 is mainly due to: (i) a net loss of approximately RMB 8.0 million from the sale of subsidiaries in 2025, compared to a one-time non-recurring income of approximately RMB 17.10 million from the sale of subsidiaries in 2024; (ii) a decrease in gross profit of approximately RMB 2.50 million in 2025 compared to the same period in 2024, primarily due to a continuous increase in the cost of Chinese herbal materials, which exceeded the increase in the selling price of the company's end products; (iii) an increase in distribution costs and administrative expenses of approximately RMB 5.0 million in this period, mainly attributed to Beijing Hangyang Health Technology Co., Ltd. and its subsidiaries, a significant portion of which was not accounted for in the same period in 2024.